<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Pharmacotherapy Barriers &#8211; BIOENGINEER.ORG</title>
	<atom:link href="https://bioengineer.org/tag/pharmacotherapy-barriers/feed/" rel="self" type="application/rss+xml" />
	<link>https://bioengineer.org</link>
	<description>Bioengineering</description>
	<lastBuildDate>Fri, 23 Jan 2026 03:34:13 +0000</lastBuildDate>
	<language>en-US</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	<generator>https://wordpress.org/?v=7.0</generator>

<image>
	<url>https://bioengineer.org/wp-content/uploads/2019/09/cropped-bioengineering-32x32.png</url>
	<title>Pharmacotherapy Barriers &#8211; BIOENGINEER.ORG</title>
	<link>https://bioengineer.org</link>
	<width>32</width>
	<height>32</height>
</image> 
<site xmlns="com-wordpress:feed-additions:1">72741379</site>	<item>
		<title>Medications for Treating Stimulant Use Disorder in Rural Clinics</title>
		<link>https://bioengineer.org/medications-for-treating-stimulant-use-disorder-in-rural-clinics/</link>
		
		<dc:creator><![CDATA[Bioengineer]]></dc:creator>
		<pubDate>Fri, 23 Jan 2026 03:33:53 +0000</pubDate>
				<category><![CDATA[Health]]></category>
		<category><![CDATA[Addiction treatment barriers]]></category>
		<category><![CDATA[Based on the content]]></category>
		<category><![CDATA[especially amphetamine-type). 2. **Pharmacotherapy Barriers:** Highlights the key challenge of medication prescription (lack of training]]></category>
		<category><![CDATA[healthcare provider training]]></category>
		<category><![CDATA[here are 5 appropriate tags focusing on the core themes: **Rural Stimulant Treatment]]></category>
		<category><![CDATA[Integrated Addiction Care]]></category>
		<category><![CDATA[Pharmacotherapy]]></category>
		<category><![CDATA[Pharmacotherapy Barriers]]></category>
		<category><![CDATA[Rural Clinics]]></category>
		<category><![CDATA[Stigma Reduction** **Explanation:** 1. **Rural Stimulant Treatment:** Directly addresses the core setting (rural clinics) and the specific disorder (stimulant use]]></category>
		<category><![CDATA[Stimulant Use Disorder]]></category>
		<guid isPermaLink="false">https://bioengineer.org/medications-for-treating-stimulant-use-disorder-in-rural-clinics/</guid>

					<description><![CDATA[In the vast landscape of substance use disorders, the emergence of amphetamine-type stimulants has become a pressing concern among healthcare professionals, particularly in rural areas. The challenges faced by primary care clinics in these regions when managing patients with amphetamine use disorder are exacerbated by a lack of specialized resources. This has led to a [&#8230;]]]></description>
		
		
		
		<post-id xmlns="com-wordpress:feed-additions:1">319621</post-id>	</item>
	</channel>
</rss>
